Valéria C. Rolla

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

Dick Menzies, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 386 citations · Full text

Public Health, Pharmacotherapy, Antimicrobial Pharmacotherapy +16

On the Take: How Medicine’s Complicity with Big Business Can Endanger your Health

Valéria C. Rolla, Marília Santini de Oliveira · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 2008 · 204 citations · Full text

Health Professions, Internal Medicine, Clinical Medicine +15

Association between Gc genotype and susceptibility to TB is dependent on vitamin D status

Adrian R. Martineau, André Cesar Leandro, Suzanne T. Anderson et al. · European Respiratory Journal · 2009 · 123 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Anemia in tuberculosis cases: A biomarker of severity?

Edson Beyker de Mendonça, Carolina AranaStanis Schmaltz, Flávia Marinho Sant’Anna et al. · PLoS ONE · 2021 · 58 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial

Müge Çevik, Lindsay C Thompson, Caryn M. Upton et al. · The Lancet Infectious Diseases · 2024 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17